Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Stibamine glucoside

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Stibamine glucoside

EINECS N/A
CAS No. 1344-34-9 Density N/A
PSA 419.50000 LogP -4.47400
Solubility N/A Melting Point N/A
Formula C36H49N3NaO22Sb3 Boiling Point N/A
Molecular Weight 1260.98 Flash Point N/A
Transport Information N/A Appearance N/A
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 1344-34-9 (STIBAMINEGLUCOSIDE) Hazard Symbols N/A
Synonyms

Stibamineglucoside;

 

Stibamine glucoside Consensus Reports

Antimony and its compounds are on The Community Right-To-Know List.

Stibamine glucoside Standards and Recommendations

OSHA PEL: TWA 0.5 mg(Sb)/m3
ACGIH TLV: TWA 0.5 mg(Sb)/m3
NIOSH REL: (Antimony) TWA 0.5 mg(Sb)/m3

Stibamine glucoside Specification

The Stibamineglucoside, with the CAS registry number 1344-34-9, is also known as  N-Glucoside of sodium 4-aminobenzenestibonate. Its molecular formula is C36H49N3NaO22Sb3 and its molecular weight is 1264.12. Additionally, its classification codes are Drug / Therapeutic Agent; Organometallic. It's used as arganic chloride catalyst and paint drier.

Other characteristics of the Stibamineglucoside can be summarised as followings: (1)#H bond acceptors: 25; (2)#H bond donors: 17; (3)#Freely Rotating Bonds: 28; (4)Polar Surface Area: 247.3 Å2; (5)H-Bond Donor: 16; (6)H-Bond Acceptor: 25; (7)Rotatable Bond Count: 16; (8)Exact Mass: 1262.982392; (9)MonoIsotopic Mass: 1260.981994; (10)Topological Polar Surface Area: 420; (11)Heavy Atom Count: 65; (12)Formal Charge: 0; (13)Complexity: 1650; (14)Isotope Atom Count: 0; (15)Defined Atom StereoCenter Count: 15; (16)Undefined Atom StereoCenter Count: 0; (17)Defined Bond StereoCenter Count: 0; (18)Undefined Bond StereoCenter Count 0; (19)Covalently-Bonded Unit Count: 2.

You can still convert the following datas into molecular structure: 
1.SMILES: [Na+].[O-][Sb](=O)(O[Sb](=O)(O[Sb](=O)(O)c1ccc(cc1)N[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)CO)c4ccc(N[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc4)c6ccc(N[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc6
2.InChI: InChI=1/3C12H16NO5.Na.H2O.6O.3Sb/c3*14-6-8-9(15)10(16)11(17)12(18-8)13-7-4-2-1-3-5-7;;;;;;;;;;;/h3*2-5,8-17H,6H2;;1H2;;;;;;;;;/q;;;+1;;;;;;;-1;;;+1/p-1/t3*8-,9-,10+,11-,12-;;;;;;;;;;;/m111.........../s1/rC36H49N3O22Sb3.Na/c40-13-22-25(43)28(46)31(49)34(57-22)37-16-1-7-19(8-2-16)62(52,53)60-64(56,21-11-5-18(6-12-21)39-36-33(51)30(48)27(45)24(15-42)59-36)61-63(54,55)20-9-3-17(4-10-20)38-35-32(50)29(47)26(44)23(14-41)58-35;/h1-12,22-51H,13-15H2,(H-,52,53,54,55);/q-1;+1/t22-,23-,24-,25-,26-,27-,28+,29+,30+,31-,32-,33-,34-,35-,36-;/m1./s1
3.InChIKey: CTZKOPZYANZEBA-GLYHEFSIBO

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 1475mg/kg (1475mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 224, 1944.
rabbit LD50 intramuscular 91mg/kg (91mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 119, 1946.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1344-34-9